SK
Samuel Kintz (PRESIDENT AND CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Enliven Therapeutics, Inc. (ELVN). The largest single filing was $273K of ELVN (12,500 sh × $21.82, as filed), executed Nov 17 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Nov 17 2025
Filed Nov 19 2025
Median ADV $83.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
ELVNRecent filings
ELVNSALE
Enliven Therapeutics, Inc.
View filing →
$273K12,500 sh × $21.82
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $267K
12,500 sh × $21.33
Exec Oct 17 2025
Filed Oct 21 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $208K
10,393 sh × $20.02
Exec Aug 18 2025
Filed Aug 20 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $106K
4,687 sh × $22.69
Exec Jul 17 2025
Filed Jul 21 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $232K
10,502 sh × $22.08
Exec Jun 17 2025
Filed Jun 18 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $150K
7,500 sh × $20.05
Exec Jun 3 2025
Filed Jun 5 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $107K
5,330 sh × $20.08
Exec May 1 2025
Filed May 5 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $260K
12,500 sh × $20.83
Exec Mar 17 2025
Filed Mar 19 2025 · 5:30 PM ET